Trial Profile
A Study Comparing Response And Relapse Rates Of Pancreaticobiliary IgG4-Related Disease In Patients Treated With Induction Rituximab Therapy Alone Versus Those Who Received Induction Followed By Rituximab Maintenance Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 May 2017
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Immunological disorders
- Focus Therapeutic Use
- 27 May 2017 New trial record
- 09 May 2017 Results presented at the Digestive Disease Week 2017.